Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma.

Cancer: Principles and Practice of Oncology.

1991 • 8,402 citations

Angiogenesis in cancer, vascular, rheumatoid and other disease

1995 • 7,717 citations

Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis

1996 • 6,878 citations

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

1997 • 5,683 citations

Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma

1991 • 5,657 citations

Cancer statistics, 1999

1999 • 3,154 citations

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

1984 • 2,762 citations

Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.

1991 • 2,598 citations

DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

1996 • 2,320 citations

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

1988 • 2,121 citations

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

1999 • 1,248 citations

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

1994 • 1,142 citations

The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1

1993 • 1,026 citations

Vascular Endothelial Growth Factor Induces Expression of the Antiapoptotic Proteins Bcl-2 and A1 in Vascular Endothelial Cells

1998 • 996 citations

Transforming Growth Factor-α: a More Potent Angiogenic Mediator than Epidermal Growth Factor

1986 • 856 citations

Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.

1997 • 841 citations

Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis.

1995 • 766 citations

Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.

1999 • 707 citations

MEMBRANE-ANCHORED GROWTH FACTORS

1993 • 676 citations

[Cancer of the pancreas].

1971 • 641 citations

Vascular Endothelial Growth Factor (VEGF)-Mediated Angiogenesis Is Associated with Enhanced Endothelial Cell Survival and Induction of Bcl-2 Expression

1999 • 638 citations

Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.

1999 • 599 citations

cdc2 is a component of the M phase-specific histone H1 kinase: Evidence for identity with MPF

1988 • 535 citations

Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology.

1993 • 534 citations

Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal

1997 • 512 citations

Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.

1992 • 500 citations

Antitumor Effects of Doxorubicin in Combination With Anti-epidermal Growth Factor Receptor Monoclonal Antibodies

1993 • 422 citations

The role of vascular endothelial growth factor in pathological angiogenesis

1995 • 419 citations

Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness.

1993 • 413 citations

K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.

1994 • 389 citations

Expression of Angiogenesis-Related Genes and Progression of Human Ovarian Carcinomas in Nude Mice

1998 • 377 citations

In Vivo Selection and Characterization of Metastatic Variants from Human Pancreatic Adenocarcinoma by Using Orthotopic Implantation in Nude Mice

1999 • 343 citations

Both v-Ha-Ras and v-Raf Stimulate Expression of the Vascular Endothelial Growth Factor in NIH 3T3 Cells

1995 • 336 citations

Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells.

1995 • 317 citations

Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy.

1997 • 314 citations

Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles.

1995 • 306 citations

Expression of interleukin-8 correlates with vascularity in human gastric carcinomas.

1998 • 262 citations

Efficacy of Antibodies to Epidermal Growth Factor Receptor Against KB Carcinoma In Vitro and in Nude Mice

1988 • 240 citations

Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle.

1987 • 230 citations

Vascular Endothelial Growth Factor Inhibits Endothelial Cell Apoptosis Induced by Tumor Necrosis Factor-α: Balance Between Growth and Death Signals

1997 • 221 citations

Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells.

2000 • 218 citations

Overexpression of HER2/neu oncogene in human pancreatic carcinoma

1993 • 217 citations

Regulation of distinct steps of angiogenesis by different angiogenic molecules.

1998 • 208 citations

Triggering signaling cascades by receptor tyrosine kinases

1992 • 168 citations

Induction and expression of amphiregulin in human pancreatic cancer.

1994 • 160 citations

Establishing a Link between Oncogenes and Tumor Angiogenesis

1998 • 148 citations

Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells.

1997 • 145 citations

Human cell line (COLO 357) of metastatic pancreatic adenocarcinoma

1980 • 141 citations

Antitumor Activity of Combined Blockade of Epidermal Growth Factor Receptor and Protein Kinase A

1996 • 141 citations

Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells.

1999 • 127 citations

Induction and Expression of Heparin-Binding EGF-Like Growth Factor in Human Pancreatic Cancer

1994 • 126 citations

Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma.

1999 • 124 citations

Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides

1997 • 122 citations

Trends in pancreatic cancer mortality in Europe, 1955–1989

1994 • 119 citations

Pancreatic carcinoma in perspective: A continuing challenge

1996 • 102 citations

Vascular Permeability Factor/Vascular Endothelial Growth Factor Inhibits Anchorage-Disruption-Induced Apoptosis in Microvessel Endothelial Cells by Inducing Scaffold Formation

1997 • 98 citations

Thiazolidine-diones. Biochemical and biological activity of a novel class of tyrosine protein kinase inhibitors.

1990 • 96 citations

Expression of Growth Factors and Growth Factor Receptors in Capillary Hemangioblastoma

1996 • 92 citations

In vivo toxicity, pharmacokinetics, and anticancer activity of Genistein linked to recombinant human epidermal growth factor.

1998 • 78 citations

Expression and partial characterization of rat protein kinase C‐δ and protein kinase C‐ξ in insect cells using recombinant baculovirus

1992 • 73 citations

Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo

1998 • 71 citations

cyl encodes a putative cytoplasmic tyrosine kinase lacking the conserved tyrosine autophosphorylation site (Y416src).

1991 • 71 citations

Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells.

1998 • 69 citations

Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed Myeloid Cells

1997 • 66 citations

bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome.

1996 • 56 citations

Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum

1996 • 55 citations

In vivo selection of a highly metastatic cell line from a human pancreatic carcinoma in the nude mouse

1992 • 53 citations

Epidermal growth factor receptor in meningiomas is expressed predominantly on endothelial cells

1988 • 47 citations

Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.

1998 • 43 citations

Benzopyranones and benzothiopyranones: a class of tyrosine protein kinase inhibitors with selectivity for the v-abl kinase.

1992 • 42 citations

Preferential Activation of the Epidermal Growth Factor Receptor in Human Colon Carcinoma Liver Metastases in Nude Mice

1998 • 37 citations

Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer

1998 • 36 citations

Large‐scale purification and characterisation of a recombinant epidermal growth‐factor receptor protein‐tyrosine kinase

1992 • 30 citations

CHEMOSENSITIZATION OF MURINE FIBROSARCOMA CELLS TO DRUGS AFFECTED BY THE MULTIDRUG RESISTANCE PHENOTYPE BY THE ANTIDEPRESSANT TRAZODONE - AN EXPERIMENTAL-MODEL FOR THE REVERSAL OF INTRINSIC DRUG-RESISTANCE

1992 • 8 citations